Raghu Rajan
About
In The Last Decade
Raghu Rajan
18 papers receiving 360 citations
Peers
Comparison fields: 5 of 59
- Pulmonary and Respiratory Medicine 104
- Surgery 101
- Oncology 94
- Rheumatology 58
- Pharmacology 51
Countries citing papers authored by Raghu Rajan
This map shows the geographic impact of Raghu Rajan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raghu Rajan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raghu Rajan more than expected).
Fields of papers citing papers by Raghu Rajan
This network shows the impact of papers produced by Raghu Rajan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raghu Rajan. The network helps show where Raghu Rajan may publish in the future.
Co-authorship network of co-authors of Raghu Rajan
This figure shows the co-authorship network connecting the top 25 collaborators of Raghu Rajan. A scholar is included among the top collaborators of Raghu Rajan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raghu Rajan. Raghu Rajan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 29 | |
| 5 | 6 | |
| 6 | Les inhibiteurs du point de contrôle immunitaire : une stratégie de dosage à privilégier | 1 |
| 7 | 5 | |
| 8 | 1 | |
| 9 | Response to chemotherapy in metastatic colorectal cancer after exposure to oxaliplatin in the adjuvant setting. | 14 |
| 10 | 8 | |
| 11 | 30 | |
| 12 | 24 | |
| 13 | 42 | |
| 14 | 7 | |
| 15 | 30 | |
| 16 | 63 | |
| 17 | 14 | |
| 18 | Do traditional Gail model risk factors account for increased breast cancer in women with lupus? | 9 |
| 19 | Prevalence of factors influencing cancer risk in women with lupus: social habits, reproductive issues, and obesity. | 35 |
| 20 | The clinical burden of prostate cancer in Canada: forecasts from the Montreal Prostate Cancer Model. | 48 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.